(Q43698918)
Statements
A phase I dose escalation and bioavailability study of oral sodium phenylbutyrate in patients with refractory solid tumor malignancies (English)
J Gilbert
S D Baker
M K Bowling
L Grochow
W D Figg
Y Zabelina
R C Donehower
M A Carducci
1 August 2001